Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal
Update (02/04/2020): The FDA has concluded an investigation into a data manipulation scandal surrounding the…
02/04/2020 - 3 minutes
Gene therapy
How Will We Be Treating Cystic Fibrosis 10 Years From Now?
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
24/03/2020 - 9 minutes
Sponsored
by Merck
Gene Therapies: Overcoming the Biggest Hurdles in Manufacturing
By 2024, the gene therapy market is expected to reach an estimated worth of $13B…
16/03/2020 - 2 minutes
This Startup Is Automating the Manufacture of Gene and Cell Therapies
In London, the firm Ori Biotech is developing an automated way to manufacture gene and…
28/02/2020 - 3 minutes
Sponsored
by Bio-Techne
Tackling the Challenges in Cell and Gene Therapy Manufacturing
The excitement about cell and gene therapies is almost tangible within the biotech and pharma…
24/02/2020 - 7 minutes
Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper
An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which…
19/02/2020 - 2 minutes
Sponsored
by Anemocyte
How Can We Tackle the Bottleneck in Plasmid Production for Gene Therapies?
The cell and gene therapy sector is booming. At the end of 2019, there were…
03/02/2020 - 5 minutes
A Future Gene Therapy Could Be Delivered in Tiny ‘Nanocontainers’
A Swiss research group has developed tiny plastic particles that could carry gene therapies to…
28/01/2020 - 3 minutes
Bluebird Bio Launches First Gene Therapy for Beta Thalassemia in Germany
The US company bluebird bio has launched the first gene therapy for the blood disorder…
14/01/2020 - 3 minutes
Eyevensys’ Gene Therapy for Blindness Boosted with €27M Series B
The French company Eyevensys has raised €27M to fund the launch of a phase II…
10/01/2020 - 3 minutes
European Biotech’s Top News in 2019
With the year coming to a close, it’s time to review the most important biotech…
30/12/2019 - 10 minutes
Freeline’s Rare Disease Gene Therapies Get €72M Series C Boost
The UK gene therapy biotech Freeline Therapeutics is to receive an investment worth €72M (£61.1M)…
20/12/2019 - 2 minutes
